Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Initiation and Maintenance Disorders | 18 | 2022 | 140 | 4.640 |
Why?
|
| Sleep | 16 | 2024 | 443 | 2.150 |
Why?
|
| Sleep Wake Disorders | 7 | 2024 | 373 | 1.990 |
Why?
|
| Menopause | 6 | 2019 | 159 | 1.410 |
Why?
|
| Pregnancy Complications | 3 | 2022 | 559 | 1.040 |
Why?
|
| Women's Health | 4 | 2019 | 197 | 0.880 |
Why?
|
| Restless Legs Syndrome | 1 | 2022 | 22 | 0.810 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2023 | 261 | 0.770 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2022 | 81 | 0.750 |
Why?
|
| Mood Disorders | 1 | 2019 | 162 | 0.620 |
Why?
|
| Premature Birth | 1 | 2022 | 408 | 0.590 |
Why?
|
| Postpartum Period | 1 | 2019 | 261 | 0.580 |
Why?
|
| Actigraphy | 3 | 2024 | 55 | 0.560 |
Why?
|
| Menstrual Cycle | 3 | 2024 | 62 | 0.550 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 245 | 0.530 |
Why?
|
| Interleukin-6 | 1 | 2018 | 1042 | 0.440 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 1041 | 0.440 |
Why?
|
| Pain | 1 | 2020 | 1697 | 0.400 |
Why?
|
| Sleep Medicine Specialty | 2 | 2020 | 7 | 0.320 |
Why?
|
| Circadian Rhythm | 4 | 2019 | 332 | 0.310 |
Why?
|
| Inflammation | 1 | 2018 | 2491 | 0.310 |
Why?
|
| Polysomnography | 5 | 2024 | 176 | 0.280 |
Why?
|
| Melatonin | 3 | 2013 | 53 | 0.270 |
Why?
|
| Emotions | 2 | 2024 | 560 | 0.270 |
Why?
|
| Postmenopause | 2 | 2017 | 377 | 0.230 |
Why?
|
| Sleep Apnea, Central | 1 | 2023 | 9 | 0.220 |
Why?
|
| Natural Language Processing | 1 | 2024 | 112 | 0.210 |
Why?
|
| Stroke Rehabilitation | 1 | 2023 | 62 | 0.210 |
Why?
|
| Menstruation | 1 | 2021 | 35 | 0.190 |
Why?
|
| Female | 23 | 2024 | 148486 | 0.190 |
Why?
|
| Self-Management | 1 | 2023 | 105 | 0.190 |
Why?
|
| Machine Learning | 1 | 2024 | 361 | 0.180 |
Why?
|
| Dreams | 1 | 2020 | 24 | 0.180 |
Why?
|
| Cognition | 3 | 2021 | 968 | 0.170 |
Why?
|
| Advisory Committees | 1 | 2020 | 196 | 0.160 |
Why?
|
| Cesarean Section | 1 | 2022 | 399 | 0.160 |
Why?
|
| Humans | 30 | 2024 | 270033 | 0.160 |
Why?
|
| Social Media | 1 | 2022 | 208 | 0.160 |
Why?
|
| Berlin | 1 | 2018 | 3 | 0.160 |
Why?
|
| Behavior Therapy | 1 | 2021 | 303 | 0.160 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 682 | 0.160 |
Why?
|
| Pregnancy | 3 | 2022 | 8107 | 0.160 |
Why?
|
| Hot Flashes | 1 | 2018 | 35 | 0.150 |
Why?
|
| Body Mass Index | 3 | 2018 | 2238 | 0.150 |
Why?
|
| Ovariectomy | 1 | 2019 | 369 | 0.150 |
Why?
|
| Orgasm | 1 | 2017 | 12 | 0.150 |
Why?
|
| Adult | 14 | 2024 | 81689 | 0.150 |
Why?
|
| Electronic Health Records | 1 | 2024 | 847 | 0.140 |
Why?
|
| Depression | 4 | 2021 | 1731 | 0.140 |
Why?
|
| Behavioral Medicine | 1 | 2016 | 15 | 0.140 |
Why?
|
| Geographic Mapping | 1 | 2016 | 13 | 0.140 |
Why?
|
| Dementia | 1 | 2021 | 474 | 0.130 |
Why?
|
| Depressive Disorder | 2 | 2011 | 563 | 0.130 |
Why?
|
| Medically Underserved Area | 1 | 2016 | 122 | 0.130 |
Why?
|
| Intimate Partner Violence | 1 | 2015 | 26 | 0.120 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 1061 | 0.120 |
Why?
|
| Sexual Behavior | 1 | 2017 | 313 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 557 | 0.120 |
Why?
|
| Pandemics | 2 | 2022 | 1603 | 0.120 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 575 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 1057 | 0.120 |
Why?
|
| Middle Aged | 15 | 2024 | 90030 | 0.120 |
Why?
|
| Affective Symptoms | 1 | 2015 | 87 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2020 | 1318 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2020 | 2843 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2018 | 728 | 0.100 |
Why?
|
| Phenotype | 1 | 2024 | 6485 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2018 | 1559 | 0.100 |
Why?
|
| Hydrocortisone | 1 | 2013 | 403 | 0.100 |
Why?
|
| Seasons | 1 | 2013 | 330 | 0.100 |
Why?
|
| Mental Health | 1 | 2015 | 412 | 0.100 |
Why?
|
| Veterans | 1 | 2023 | 1735 | 0.100 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 5906 | 0.090 |
Why?
|
| Heart Failure | 1 | 2023 | 2319 | 0.080 |
Why?
|
| Progesterone | 2 | 2009 | 711 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8668 | 0.080 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2009 | 96 | 0.080 |
Why?
|
| Affect | 2 | 2024 | 305 | 0.080 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2007 | 224 | 0.070 |
Why?
|
| Young Adult | 6 | 2024 | 22134 | 0.070 |
Why?
|
| Comorbidity | 2 | 2024 | 2389 | 0.070 |
Why?
|
| Biomarkers | 1 | 2018 | 5046 | 0.070 |
Why?
|
| Sexual Partners | 2 | 2017 | 103 | 0.060 |
Why?
|
| Estrogens | 1 | 2009 | 808 | 0.060 |
Why?
|
| Unsupervised Machine Learning | 1 | 2024 | 20 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2012 | 906 | 0.060 |
Why?
|
| Benzhydryl Compounds | 1 | 2004 | 83 | 0.060 |
Why?
|
| Aged | 7 | 2024 | 73127 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 1145 | 0.050 |
Why?
|
| Hemiplegia | 1 | 2023 | 48 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 219 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2007 | 762 | 0.050 |
Why?
|
| Male | 10 | 2024 | 127917 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2024 | 1068 | 0.050 |
Why?
|
| Logistic Models | 2 | 2019 | 3438 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 279 | 0.040 |
Why?
|
| Adolescent | 4 | 2024 | 32647 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 187 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 2056 | 0.040 |
Why?
|
| Neoplasms | 2 | 2024 | 15902 | 0.040 |
Why?
|
| Quality of Life | 2 | 2024 | 4772 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 4360 | 0.040 |
Why?
|
| Medicare | 1 | 2023 | 925 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 214 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2024 | 9464 | 0.030 |
Why?
|
| Cities | 1 | 2016 | 57 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2017 | 87 | 0.030 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2017 | 135 | 0.030 |
Why?
|
| Survivors | 1 | 2021 | 1022 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 4470 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2023 | 39736 | 0.030 |
Why?
|
| Fatigue | 1 | 2021 | 1278 | 0.030 |
Why?
|
| Age Factors | 1 | 2024 | 5449 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 649 | 0.030 |
Why?
|
| Darkness | 1 | 2013 | 37 | 0.030 |
Why?
|
| Periodicity | 1 | 2013 | 72 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 2489 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2020 | 1041 | 0.030 |
Why?
|
| Light | 1 | 2013 | 279 | 0.030 |
Why?
|
| United States | 2 | 2023 | 15776 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2021 | 33691 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 729 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 2388 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 452 | 0.020 |
Why?
|
| Child | 2 | 2021 | 30466 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 210 | 0.020 |
Why?
|
| Time Factors | 2 | 2013 | 12953 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2007 | 165 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 676 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 131 | 0.020 |
Why?
|
| Reaction Time | 1 | 2007 | 237 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 2316 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 916 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 239 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5566 | 0.020 |
Why?
|
| Perception | 1 | 2007 | 349 | 0.020 |
Why?
|
| Estradiol | 1 | 2007 | 828 | 0.010 |
Why?
|
| Memory | 1 | 2007 | 445 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 13378 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 12019 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 6752 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 17824 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 15172 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 30923 | 0.010 |
Why?
|